Cervical Squamous Cell Carcinoma (DBCOND0029361)

Identifiers

Synonyms
Squamous Cell Carcinoma (SCC) of the Cervix / Squamous Cell Carcinoma of the Cervix / Squamous Cell Carcinoma of Cervix / Cervical Squamous Cell Cancer / Cervical Cancer Squamous Cell / Squamous cell carcinoma of cervix (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01639625
Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local ApplicationNot Available2completed
NCT03357757
Avelumab With Valproic Acid in Virus-associated Cancertreatment2active_not_recruiting
NCT02042885
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerNo drug interventionstreatment1 / 2terminated
NCT03221400
PEN-866 in Patients With Advanced Solid Malignanciestreatment1 / 2unknown_status
NCT03894618
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasNo drug interventionstreatment1completed
NCT02765919
A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine CervixNo drug interventionstreatment3completed
NCT02879214
Simultaneously Integrated Dose Escalation for Locally Advanced Cervical CancerNo drug interventionstreatment2unknown_status
NCT00025233
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervixtreatment2completed
NCT00217633
Pelvic Exenteration in Treating Patients With Recurrent Cervical CancerNo drug interventionstreatment2completed
NCT00559377
FDG and FMISO PET Hypoxia Evaluation in Cervical CancerNo drug interventionsdiagnostic2completed
NCT06232083
Application of PLDR External Irradiation Combined With Immune Checkpoint Inhibitors in Recurrent Cervical CancerNo drug interventionstreatment1 / 2recruiting
NCT01693783
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancertreatment2completed
NCT05613283
Primary Cervical Cancer Screening by Self-sampling HPV TestNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03738228
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancertreatment1active_not_recruiting
NCT00031993
Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervixtreatment2completed
NCT04976478
Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell CarcinomaNot AvailableNot Availablenot_yet_recruiting
NCT00309959
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT00068549
Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancertreatment1completed
NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutationstreatment0completed
NCT04678791
Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell CarcinomatreatmentNot Availablenot_yet_recruiting
NCT01649089
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01026792
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgerytreatment2completed
NCT00017004
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemiasupportive_care3completed
NCT00416455
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerNo drug interventionsdiagnostic1 / 2completed
NCT00262821
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancertreatment3terminated
NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumorstreatment1active_not_recruiting
NCT00064077
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervixtreatment3completed
NCT01266447
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT02164461
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancertreatment1completed
NCT02466971
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancerstreatment3active_not_recruiting
NCT02020707
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancerstreatment1completed
NCT01365156
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for CervixNo drug interventionstreatment3completed
NCT00070317
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerdiagnosticNot Availableterminated
NCT00057863
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancertreatment2completed
NCT05210348
Clinical Evaluation of Detection of High Risk HPV in UrineNo drug interventionsNot AvailableNot Availableunknown_status
NCT00389974
Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgerytreatment2completed
NCT00499031
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancertreatment2completed
NCT06543576
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancertreatment1 / 2not_yet_recruiting
NCT00803062
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancertreatment3completed
NCT02562729
Complete Nerve-Sparing Radical Hysterectomy for Cervical CancerNo drug interventionstreatment2completed
NCT00054444
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancertreatment1completed
NCT05013268
Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinomatreatment1unknown_status
NCT01807546
Oral Rigosertib for Squamous Cell Carcinomatreatment2completed
NCT00104910
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancertreatment1completed
NCT01759355
Hybrid PET/MR in the Therapy of Cervical CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01835171
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancertreatment2active_not_recruiting
NCT01351103
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligandstreatment1active_not_recruiting
NCT01899404
MRI FDG PET Imaging CervixNo drug interventionsdiagnosticNot Availablecompleted
NCT01539668
Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote AreasNo drug interventionsNot AvailableNot Availablecompleted